MedPath

In vivo characterisation of pressure wave propagation in the rectosigmoid region as a target for neuromodulation for faecal incontinence

Completed
Conditions
faecal incontinence
Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
Registration Number
ACTRN12615001137583
Lead Sponsor
niversity of Auckland
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
18
Inclusion Criteria

1. Age > 18 years.
2. Patients with faecal incontinence who are clinically indicated for sacral neuromodulator placement after being reviewed by pelvic floor specialist surgeons at Auckland City Hospital.
3. Able to understand risks and benefits of the study.
4. Able to give informed consent.

Exclusion Criteria

1. Pregnancy.
2. Previously undergone distal colon or rectal resection.
3. Presence of slow transit constipation.
4. Metabolic, neurogenic or endocrine disorders known to cause colonic dysmotility (e.g. multiple sclerosis, Parkinson’s disease, untreated hypothyroidism).
5. Previous lumbo-­-sacral injury, surgery, or malformation.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath